Posts Tagged ‘anxiety’

Australia’s growing drug problem—Elderly overprescribed antidepressants

Friday, May 21st, 2010

The University of Queensland, Australia
May 21, 2010

Older Australians are being overprescribed medications for depression, according to a study by University of Queensland researchers published today in the Australian and New Zealand Journal of Psychiatry.

Dr Samantha Hollingworth, Senior Research Fellow at the School of of Population Health, said the study found very high prescribing rates in older Australians, especially those over 85 years old despite national mental health data indicating that depression and anxiety was a decreasing problem in this age group.

“While the under 50s have a higher prevalence of depression and anxiety, it is the over 85s who are receiving the most medication,” Dr Hollingworth said.

The study found that the prevalence and treatment of depressive and anxiety disorders are highest in those aged under 50, after which it declines rapidly. There are peaks in prescribing of antidepressants in those aged in their late 50s and early 90s, with the highest use in those aged 90-94 years.

Co-author, Professor Harvey Whiteford, Kratzmann Professor of Psychiatry and Population Health with the Queensland Centre for Mental Health Research, said it appeared older Australians were receiving antidepressant medications for reasons other than the treatment of conditions for which these drugs have marketing approval, or for depressive and anxiety symptoms that do not reach the threshold for a diagnosis.

Read entire article:  http://www.uq.edu.au/news/?article=21193

« Return to news items


Share

AstraZeneca Fined $520 Million Over Illegal Marketing of its Antipsychotic Drug Seroquel

Thursday, April 29th, 2010

InjuryBoard.com
By Jane Akre
April 28, 2010

Pharmaceutical Giant, AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million after being fined by the federal government for illegally marketing the anti-psychotic drug, Seroquel.

Seroquel, also known as quetiapine fumarate, was approved by the FDA in 1997 to treat psychotic disorders. By October 2006, its use had expanded for use for bipolar depression and mania.

The Department of Justice alleges AstraZeneca illegally marketed Seroquel for uses other than those approved by the FDA such as Alzheimer’s disease, anger management, anxiety, ADD, dementia, depression, PTSD, mood disorders, among other uses considered “off-label.”

In 2008, Bloomberg reported that teenagers and the elderly were increasingly being given a class of anti-psychotic drugs not cleared by regulators. In adolescents, the medications are given for depression, autism and hyperactivity, and in the elderly for dementia and insomnia.

Half of Seroquel sales in 2006 were reportedly for off-label use.

In doing so, the company submitted false claims for payments from federal insurance programs including Medicaid, Medicare and TRICARE programs, Veterans Affairs, the Bureau of Prisons, and the Federal Employee Health Benefits Program.

Read entire article:  http://www.injuryboard.com/national-news/astrazeneca-fined-520-million-over-illegal-seroquel-marketing.aspx?googleid=280742

« Return to news items


Share

On Earth Day, with Green Causes in the Forefront, Here is a Video about Green Mental Health

Thursday, April 22nd, 2010

Psychiatry’s solution to life’s problems is stigmatizing psychiatric labels and the administration of toxic drugs which international drug regulatory agencies have warned can cause mania, worsening depression, anxiety, delusions, seizures, liver failure, suicide, mania, heart attack, stroke, fatal blood clots, sudden death, diabetes and much more.

(See http://www.cchrint.org/psychdrugdangers/)

Green Mental Health Care is a non-toxic, non-addictive and non-invasive approach to mental health which focuses on workable medical, not psychiatric, solutions that have better patient outcomes and are not harmful or toxic to those seeking help.  The focus is on finding underlying medical causes that can manifest as psychiatric “symptoms” without  the need for subjective psychiatric labels and deadly drugs.  For more information on medical alternatives to toxic drugs, visit  http://www.cchrint.org/alternatives/

View video on Green Mental Health here.

« Return to news items


Share

Pill popping: “The misconception is that prescription drugs aren’t dangerous because a doctor gives them out”

Monday, April 12th, 2010

The Purdue University Calumet Chronicle
By Andrea Drac
April 12, 2010

According to the National Institute of Drug Abuse (NIDA)’s survey the National Survey on Drug Use and Health, in 2008 15.2 million Americans age 12 and older had taken a prescription pain reliever, tranquilizer, stimulant, or sedative for nonmedical purposes at least once in the year.

Addiction to and the abuse of prescription drugs, also known as “pill popping,” has become a national trend. According to Ivan Budisin, a psychologist at the PUC Counseling Center, pill popping has become a trend due to the fact that prescription drugs are becoming more available.

“In 1991, according to the National Institute of Drug Abuse there were 40 million orders for prescription drugs sent out,” said Budisin. “In 2001, 180 million orders were sent out. It’s a huge increase.”

According to an article on the NIDA web site entitled, “Prescription Drug Abuse – Topics in Brief,” the three most commonly abused classes of prescription drugs are Opioids such as Vicodin, which are often prescribed to treat pain; Central Nervous System (CNS) depressants such as Valium, which are used to treat anxiety and sleep disorders; and stimulants such as Ritalin, which are prescribed to treat certain sleep disorders and attention deficit hyperactivity disorder (ADHD).

Budisin said that prescription drug addiction is most popular among high school and college students due to easy access, either by taking their own prescription drugs for non-medicinal purposes, or taking someone else’s prescription drugs for non-medicinal purposes. Another reason for addiction has to do with cost; prescription drugs do not cost a lot of money, so it is easy to afford.

There is also a huge misconception involved in prescription drug abuse and addiction, which makes it such a huge trend.

“The misconception is that prescription drugs aren’t dangerous because a doctor gives them out,” said Budisin.

Read entire article:  http://media.www.pucchronicle.com/media/storage/paper1082/news/2010/04/12/News/Pill-Popping-3903522.shtml

« Return to news items


Share

More U.S. Senators voice alarm over 400% increase in psychiatric drugging of troops & increased military suicides

Friday, March 26th, 2010

Arizona Daily Star
March 26, 2010

A group of U.S. senators has raised concern that the use of antidepressants and other prescription drugs for treatment of mental disorders is on the rise in the military, particularly among troops in Iraq and Afghanistan.

Sen. Jim Webb, D-Va., who led the Senate Armed Services Committee’s personnel subcommittee hearing in Washington this week, said the apparent increase in prescriptions is “on its face, pretty astounding and troubling.”

Sen. Benjamin Cardin, D-Md., who has been speaking out for months about the rise in prescribed drugs and how they may be harmful to younger soldiers, said at the hearing that the military needs to examine whether increased use of medicines has any link to an increase in military suicides.

Department of Defense statistics show that from 2005 to 2008, “there was a 400 percent increase in the prescription of antidepressants and other drugs used to treat anxiety,” Cardin said. And a 2007 Army report showed that about 12 percent of combat troops in Iraq and 17 percent of those in Afghanistan were taking antidepressants or sleeping pills.

In 2009, 160 active-duty Army suicides were reported – a 15 percent increase from the previous year, Cardin said.

“We need the Department of Defense’s help in trying to understand what is happening,” he said. “We have a lot of dots, but we haven’t connected the dots.”

Top medical officers who testified at the hearing took issue with some of Cardin’s statistics but acknowledged that there has been an increase in the use of psychotropic drugs prescribed to treat mental disorders.

“The use of psychotropic medication in the nation as a whole has increased,” said Charles Rice, the acting assistant secretary of defense for health affairs.

“It’s difficult to turn on the television without being convinced that you’re bipolar or have some other problem for which there is a drug ready-made for you.”

Read entire article:  http://www.azstarnet.com/news/national/article_5c54a003-41a2-510a-a07a-35c893cd1c76.html

« Return to news items


Share

Senator Calls for Probe of Military Suicides & Antidepressant Use citing 400% increase in psych drug prescriptions

Wednesday, March 24th, 2010

The Baltimore Sun
March 24, 2010

Sen. Ben Cardin of Maryland called Wednesday for a government-funded investigation into possible links between the growing use of anti-depressants by members of the military and high rates of suicide among men and women in uniform.

The Democratic senator, in remarks to a Senate Armed Services subcommittee, said that only “a proper scientific study” can determine whether “DOD is prescribing anti-depressants to its service members appropriately.”

Cardin quoted from the most recent Defense department statistics, covering 2005 to 2008, which showed a 400 percent increase in prescriptions for antidepressants and other drugs used to combat anxiety. The senator called those numbers “disturbing.”

At the same time, other government figures have reflected a significant increase in suicides among those in uniform. For example, in 2009, there were 160 suicides among active-duty members of the U.S. Army, a 15 percent increase over 2008.

Cardin called the number of suicides “unprecedented” and asked whether there was a relationship between the use of antidepressants and “the alarming rate of suicides” in the military.

He said the Food and Drug Administration has expressed concerns about many of the same drugs prescribed routinely for troops battling anxiety and depression. The FDA’s interest has led drug manufacturers to revise warning labels on their products to indicate that young adults, ages 18 to 24, may be at “elevated risk of suicidal thought and behavior while using these medications,” said Cardin.

Roughly two in five U.S. servicemen and women serving in Afghanistan and Iraq fall into the 18-24 age bracket, the senator said. About two in five Army suicide victims in 2006 and 2007 were believed to have taken anti-depressants, Cardin added.

Read entire article:  http://weblogs.baltimoresun.com/news/local/politics/2010/03/cardin_calls_for_probe_of_mili.html

« Return to news items


Share

Drug Giant AstraZeneca to drop psychiatric drug research for schizophrenia, bipolar, depression & anxiety drugs

Tuesday, March 2nd, 2010

Reuters
By Ben Hirschler
March 2, 2010

AstraZeneca (AZN.L) is to stop researching some disease areas that form the backbone of its current business — including schizophrenia and acid reflux — in a drive to focus R&D efforts and cut costs.

The Anglo-Swedish drugmaker, which faces one of the sector’s worst “cliffs” of expiring drug patents, told its staff on Tuesday it would cease discovery in 10 of its current disease areas, or around one quarter of the total.

A wide-ranging overhaul had been expected since the group said in January it was cutting a further 8,000 staff, or some 12 percent of the workforce, including a net 1,800 in research. But it is only now that staff know where the axe will fall.

AstraZeneca is not alone in taking the knife to previously sacrosanct R&D, though its cuts are particularly deep. Pfizer (PFE.N) and GlaxoSmithKline (GSK.L) are also ditching drug discovery work that does not pay its way. [ID:nLDE61408I]

Read entire article:  http://www.reuters.com/article/idUSLDE62019Q20100302?type=marketsNews

« Return to news items


Share

Depressed? Have anxiety? Psychiatry has a solution; the new ‘improved’ lobotomy. Just burn some holes in that brain.

Friday, November 27th, 2009

Benedict Carey
The New York Times
November 26, 2009

One was a middle-aged man who refused to get into the shower. The other was a teenager who was afraid to get out.

The man, Leonard, a writer living outside Chicago, found himself completely unable to wash himself or brush his teeth. The teenager, Ross, growing up in a suburb of New York, had become so terrified of germs that he would regularly shower for seven hours. Each received a diagnosis of severe obsessive-compulsive disorder, or O.C.D., and for years neither felt comfortable enough to leave the house.

But leave they eventually did, traveling in desperation to a hospital in Rhode Island for an experimental brain operation in which four raisin-sized holes were burned deep in their brains.

Today, two years after surgery, Ross is 21 and in college. “It saved my life,” he said. “I really believe that.”

The same cannot be said for Leonard, 67, who had surgery in 1995. “There was no change at all,” he said. “I still don’t leave the house.”

Both men asked that their last names not be used to protect their privacy.

The great promise of neuroscience at the end of the last century was that it would revolutionize the treatment of psychiatric problems. But the first real application of advanced brain science is not novel at all. It is a precise, sophisticated version of an old and controversial approach: psychosurgery, in which doctors operate directly on the brain.

Read entire article: http://www.nytimes.com/2009/11/27/health/research/27brain.html?_r=3&partner=rss&emc=rss

« Return to news items


Share